Endothelial Repair and Regeneration Following Intimal Injury

Overview

Journal J Cardiovasc Transl Res

Publisher Springer

Specialty Cardiology & Vascular Diseases

Date 2016 Jan 23

PMID 26797874

Citations 21

Authors

Belay Tesfamariam

Affiliations

Soon will be listed here.

Abstract

Coronary artery intervention using device implants significantly reduce the risk of restenosis and the need for revascularization but are associated with endothelial denudation and impaired function. This may be due to incomplete endothelial recovery as a result of intimal injury, presence of polymer and/or high antiproliferative drug accumulation in the intima. The permanent presence of a metal prosthesis or polymer may impair the proliferation of resident endothelial cells to cover empty areas. Attention has focused on the robust replenishment of endothelial monolayer by recruitment of circulating endothelial progenitor cells derived from the bone marrow to areas of endothelial injury. The balance between endothelial damage and repair is critical for the maintenance of intimal integrity, function, and prevention of thrombotic complications. This review will discuss on the aftereffects of intravascular device implants on endothelial injury and the pathways involved in endothelial repair and regeneration with an emphasis on endothelial progenitor cells.

Citing Articles

Regeneration of Vascular Endothelium in Different Large Vessels.

Sesorova I, Bedyaev E, Vavilov P, Levin S, Mironov A Int J Mol Sci. 2025; 26(2).

PMID: 39859550 PMC: 11766047. DOI: 10.3390/ijms26020837.

Sodium tanshinone IIA sulfonate ameliorates neointima by protecting endothelial progenitor cells in diabetic mice.

Heng Y, Shang H, Zhang X, Wei W BMC Cardiovasc Disord. 2023; 23(1):446.

PMID: 37697234 PMC: 10494373. DOI: 10.1186/s12872-023-03485-4.

Human Umbilical Cord Blood Endothelial Progenitor Cell-Derived Extracellular Vesicles Control Important Endothelial Cell Functions.

Fraj S, Naserian S, Lorenzini B, Goulinet S, Mauduit P, Uzan G Int J Mol Sci. 2023; 24(12).

PMID: 37373015 PMC: 10297996. DOI: 10.3390/ijms24129866.

Biomarkers and the outcomes of ischemic stroke.

Huang Y, Wang Z, Huang Z, Liu Z Front Mol Neurosci. 2023; 16:1171101.

PMID: 37342100 PMC: 10277488. DOI: 10.3389/fnmol.2023.1171101.

Corroded iron stent increases fibrin deposition and promotes endothelialization after stenting.

Deng Y, Wen Y, Yin J, Huang J, Zhang R, Zhang G Bioeng Transl Med. 2023; 8(3):e10469.

PMID: 37206231 PMC: 10189476. DOI: 10.1002/btm2.10469.

References

Cai H . NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ Res. 2005; 96(8):818-22. DOI: 10.1161/01.RES.0000163631.07205.fb. View

Jimenez J, Davies P . Hemodynamically driven stent strut design. Ann Biomed Eng. 2009; 37(8):1483-94. PMC: 2819751. DOI: 10.1007/s10439-009-9719-9. View

Holy E, Jakob P, Eickner T, Camici G, Beer J, Akhmedov A . PI3K/p110α inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent design. Eur Heart J. 2013; 35(12):808-20. DOI: 10.1093/eurheartj/eht496. View

Camici G, Steffel J, Amanovic I, Breitenstein A, Baldinger J, Keller S . Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents. Eur Heart J. 2009; 31(2):236-42. DOI: 10.1093/eurheartj/ehp259. View

Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T . Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002; 8(4):403-9. DOI: 10.1038/nm0402-403. View

Wang X, Zachman A, Chun Y, Shen F, Hwang Y, Sung H . Polymeric stent materials dysregulate macrophage and endothelial cell functions: implications for coronary artery stent. Int J Cardiol. 2014; 174(3):688-95. PMC: 4070878. DOI: 10.1016/j.ijcard.2014.04.228. View

Konstantinides S, Schafer K, Thinnes T, Loskutoff D . Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice. Circulation. 2001; 103(4):576-83. DOI: 10.1161/01.cir.103.4.576. View

Sabatier F, Camoin-Jau L, Anfosso F, Sampol J, Dignat-George F . Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence. J Cell Mol Med. 2009; 13(3):454-71. PMC: 3822508. DOI: 10.1111/j.1582-4934.2008.00639.x. View

Massberg S, Schulz C, Gawaz M . Role of platelets in the pathophysiology of acute coronary syndrome. Semin Vasc Med. 2004; 3(2):147-62. DOI: 10.1055/s-2003-40673. View

10.

Rafii S, Lyden D . Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003; 9(6):702-12. DOI: 10.1038/nm0603-702. View

11.

Szmitko P, Fedak P, Weisel R, Stewart D, Kutryk M, Verma S . Endothelial progenitor cells: new hope for a broken heart. Circulation. 2003; 107(24):3093-100. DOI: 10.1161/01.CIR.0000074242.66719.4A. View

12.

Nakano M, Yahagi K, Otsuka F, Sakakura K, Finn A, Kutys R . Causes of early stent thrombosis in patients presenting with acute coronary syndrome: an ex vivo human autopsy study. J Am Coll Cardiol. 2014; 63(23):2510-2520. DOI: 10.1016/j.jacc.2014.02.607. View

13.

Pendyala L, Li J, Shinke T, Geva S, Yin X, Chen J . Endothelium-dependent vasomotor dysfunction in pig coronary arteries with Paclitaxel-eluting stents is associated with inflammation and oxidative stress. JACC Cardiovasc Interv. 2009; 2(3):253-62. DOI: 10.1016/j.jcin.2008.11.009. View

14.

Nuhrenberg T, Voisard R, Fahlisch F, Rudelius M, Braun J, Gschwend J . Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty. FASEB J. 2004; 19(2):246-8. DOI: 10.1096/fj.04-2431fje. View

15.

van Beusekom H, Sorop O, van den Heuvel M, Onuma Y, Duncker D, Danser A . Endothelial function rather than endothelial restoration is altered in paclitaxel- as compared to bare metal-, sirolimusand tacrolimus-eluting stents. EuroIntervention. 2010; 6(1):117-25. View

16.

Shantsila E, Watson T, Lip G . Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol. 2007; 49(7):741-52. DOI: 10.1016/j.jacc.2006.09.050. View

17.

Tesfamariam B . Drug release kinetics from stent device-based delivery systems. J Cardiovasc Pharmacol. 2008; 51(2):118-25. DOI: 10.1097/FJC.0b013e318158540f. View

18.

Otsuka F, Byrne R, Yahagi K, Mori H, Ladich E, Fowler D . Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J. 2015; 36(32):2147-59. DOI: 10.1093/eurheartj/ehv205. View

19.

Jabs A, Gobel S, Wenzel P, Kleschyov A, Hortmann M, Oelze M . Sirolimus-induced vascular dysfunction. Increased mitochondrial and nicotinamide adenosine dinucleotide phosphate oxidase-dependent superoxide production and decreased vascular nitric oxide formation. J Am Coll Cardiol. 2008; 51(22):2130-8. DOI: 10.1016/j.jacc.2008.01.058. View

20.

Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett N . Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002; 109(5):625-37. PMC: 2826110. DOI: 10.1016/s0092-8674(02)00754-7. View